Clinical Trial Update: The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating the effects of a flaxseed supplement on biochemical factors and hepatic fibrosis in patients with nonalcoholic steatohepat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Flaxseed supplement (Linum usitatissimum seed supplement)

Snippet

Sponsor: National Nutrition and Food Technology Institute | Conditions: Non Alcoholic Steatohepatitis | Phase 2, Phase 3 | Status: COMPLETED